FDA Okays First Drug for Migraine Prevention in AdolescentsFDA Okays First Drug for Migraine Prevention in Adolescents

The FDA has approved topiramate for prophylaxis of migraine in adolescents aged 12 to 17, the first such approval for this age group. FDA Approvals
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery News Alert Source Type: news